Roche’s diagnosis access program expanded to tuberculosis, hepatitis
Roche today announced that its Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low ...
